The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
News-Medical.Net on MSN12h
Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetesSemaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback